OTCMKTS:CHEOF Cochlear (CHEOF) Stock Price, News & Analysis $178.59 0.00 (0.00%) (As of 11/4/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartFinancialsSEC FilingsShort Interest About Cochlear Stock (OTCMKTS:CHEOF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Cochlear alerts:Sign Up Key Stats Today's Range$178.59▼$178.5950-Day Range$178.59▼$209.2752-Week Range$158.45▼$237.38VolumeN/AAverage Volume173 shsMarket CapitalizationN/AP/E Ratio108.76Dividend Yield0.71%Price TargetN/AConsensus RatingN/A Company OverviewCochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.Read More… Unveiled: NVIDIA’s "Secret Royalty" Program (Ad)Did you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip?Click Here to learn how to get in now >>> Receive CHEOF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cochlear and its competitors with MarketBeat's FREE daily newsletter. Email Address CHEOF Stock News HeadlinesAnalysts Offer Insights on Healthcare Companies: Terns Pharmaceuticals (TERN) and Cochlear Limited (OtherCHEOF)July 26, 2023 | markets.businessinsider.comChandy’s Cochlear Implant Scheme hits hurdles, parents seek government helpJuly 20, 2023 | msn.comThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse. November 5, 2024 | Porter & Company (Ad)Sensorion Submits Clinical Trial Application for OTOF-GT, its Lead Gene Therapy Candidate, in EuropeJuly 19, 2023 | benzinga.com7-year-old girl hears for first time after Chhattisgarh govt sponsors operation, father wants her to become doctorJuly 18, 2023 | msn.comOommen Chandy: Humane leader who put patients first, say health expertsJuly 18, 2023 | msn.comMorgan Stanley Keeps Their Hold Rating on Cochlear Limited (CHEOF)July 10, 2023 | markets.businessinsider.comSensorion Submits Clinical Trial Application for Lead Gene Therapy Candidate OTOF-GT in the UKJuly 10, 2023 | benzinga.comSee More Headlines CHEOF Stock Analysis - Frequently Asked Questions How have CHEOF shares performed this year? Cochlear's stock was trading at $198.50 at the beginning of the year. Since then, CHEOF stock has decreased by 10.0% and is now trading at $178.59. View the best growth stocks for 2024 here. How do I buy shares of Cochlear? Shares of CHEOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolOTCMKTS:CHEOF CUSIPN/A CIK1453930 Webwww.cochlear.com Phone(129) 428-6555FaxN/AEmployees4,800Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio108.76 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (OTCMKTS:CHEOF) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cochlear Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Cochlear With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.